Do you want to read an article? Please log in or register.
Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer
Lung, Respiratory and Thoracic Cancer
